title: Stage I-II follicular lymphoma: an endangered species?
authors.affiliation: a M. D. Anderson Cancer Center, University of Texas , Houston , Texas , USA.
authors.forename: Peter
authors.initials: P
authors.lastname: McLaughlin
authors.affiliation: b Department of Haematology , Peter MacCallum Cancer Centre , East Melbourne , VIC , Australia.
authors.forename: John F
authors.initials: JF
authors.lastname: Seymour
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008224:Lymphoma, Follicular / Q000473:pathology* / Q000628:therapy*; D008297:Male; D011878:Radiotherapy; D000069283:Rituximab / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D000069283:Rituximab